PERINDOPRIL-GX perindopril arginine 10mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril-gx perindopril arginine 10mg film-coated tablet blister pack

medis pharma pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; lactose monohydrate; magnesium stearate; maltodextrin; colloidal anhydrous silica; glycerol dibehenate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL-MEDIS perindopril arginine 10mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril-medis perindopril arginine 10mg film-coated tablet bottle

medis pharma pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maltodextrin; colloidal anhydrous silica; glycerol dibehenate; magnesium stearate; sodium starch glycollate type a; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL-ZP perindopril arginine 10mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril-zp perindopril arginine 10mg film-coated tablet bottle

medis pharma pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: glycerol dibehenate; sodium starch glycollate type a; lactose monohydrate; maltodextrin; magnesium stearate; colloidal anhydrous silica; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL-ZP perindopril arginine 10mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril-zp perindopril arginine 10mg film-coated tablet blister pack

medis pharma pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: maltodextrin; lactose monohydrate; sodium starch glycollate type a; glycerol dibehenate; magnesium stearate; colloidal anhydrous silica; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL-GX perindopril arginine 10mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril-gx perindopril arginine 10mg film-coated tablet bottle

medis pharma pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; magnesium stearate; maltodextrin; sodium starch glycollate type a; glycerol dibehenate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL-AS perindopril arginine 10mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril-as perindopril arginine 10mg film-coated tablet bottle

medis pharma pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; glycerol dibehenate; magnesium stearate; lactose monohydrate; colloidal anhydrous silica; maltodextrin; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Perindopril Arginine/Amlodipine 5/10 APOTEX perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 5/10 apotex perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 5 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

PERINDOPRIL/AMLODIPINE-ZP 5/10 perindopril arginine 5 mg/amlodipine 10 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril/amlodipine-zp 5/10 perindopril arginine 5 mg/amlodipine 10 mg tablet bottle

medis pharma pty ltd - amlodipine besilate, quantity: 13.88 mg; perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: glycerol dibehenate; microcrystalline cellulose; calcium hydrogen phosphate; crospovidone; sodium starch glycollate; light magnesium oxide; trehalose dihydrate; magnesium stearate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

PERINDOPRIL/AMLODIPINE-WT 5/10 perindopril arginine 5 mg/amlodipine 10 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril/amlodipine-wt 5/10 perindopril arginine 5 mg/amlodipine 10 mg tablet bottle

medis pharma pty ltd - amlodipine besilate, quantity: 13.88 mg; perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: light magnesium oxide; microcrystalline cellulose; sodium starch glycollate; trehalose dihydrate; magnesium stearate; glycerol dibehenate; calcium hydrogen phosphate; crospovidone - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

PERINDOPRIL/AMLODIPINE-MEDIS 5/10 perindopril arginine 5 mg/amlodipine 10 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril/amlodipine-medis 5/10 perindopril arginine 5 mg/amlodipine 10 mg tablet bottle

medis pharma pty ltd - amlodipine besilate, quantity: 13.88 mg; perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: sodium starch glycollate; light magnesium oxide; microcrystalline cellulose; trehalose dihydrate; calcium hydrogen phosphate; crospovidone; glycerol dibehenate; magnesium stearate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.